HALO vs LYB · P/E 15, rev $857.7M vs P/E 21, rev $16.37B
Halozyme Therapeutics Inc (HALO) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the HALO and LYB stock pages for the full models.
Not investment advice.